首页> 美国政府科技报告 >Breast Tumor-Generated Type 1 Collagen Breakdown Fragments Act as Matrikines to Drive Osteolysis
【24h】

Breast Tumor-Generated Type 1 Collagen Breakdown Fragments Act as Matrikines to Drive Osteolysis

机译:乳腺肿瘤产生的1型胶原蛋白分解片段作为matrikines驱动骨溶解

获取原文

摘要

The major site of metastasis of breast cancer cells is bone. Bone metastases occur in 80% of patients with advanced disease and causes significant morbidity. The mechanisms of osteolysis and targeting of bone by the breast cancer cells are still unknown. The osteolysis that occurs in patients is mediated by factors that come from the tumor cells. The tumor cells provide a microenvironment to the osteoblasts and osteoclasts. Bone remodeling requires the degradation and turnover of type I collagen. Type I collagen is a triple helical fibrillar collagen that can be cleaved by cathepsin K found only in osteoclasts. Recently, studies of breakdown fragments of extracellular matrix (ECM) proteins have shown novel biological activity of the fragments. We believe that these fragments may be chemotactic to breast tumor cells. Once the breast tumor cells metastasize to the bone, the tumor cells secrete factors that stimulate the increase in osteolysis of bone. This leads to increase of type I collagen fragments that signal back to the tumor cells, osteoblasts and osteoclasts perpetuating this cascade. This study proposes to map the active sequences in the type I collagen breakdown fragments that can contribute to breast tumor metastasis to bone. The understanding of this pathway can lead to development of biomarkers assays to detect early bone metastases, monitor treatments in targeting bone metastases and staging of metastatic bone tumors. Prevention, early detection and treatment of bone metastasis breast tumors to bone would benefit the survival and quality of life of breast cancer patients.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号